arrow
L

Lourdes Gimeno

Clinic University Hospital Virgen de la Arrixaca and Biomedical Research Institute of Murcia Pascual Parrilla
H指数:16
被引数:894

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ethylbenzene Exposure and Bronchoalveolar CD4/CD8 T Cells in Hypersensitivity Pneumonitis Development and Clinical Outcome

乙苯暴露与高敏性肺炎发展中支气管肺泡灌洗液中CD4/CD8 T细胞及其临床结局

2026-03-030
OAAI
HLA class-I genotyping to personalize Bacille Calmette–Guerin immunotherapy in bladder cancer

HLA class-I基因分型用于个性化膀胱癌的Bacille Calmette–Guerin免疫疗法

2025-12-120
OAAI
Interplay of KIR2DL5; nitric oxide; and tobacco smoking in predisposition to bladder cancer

KIR2DL5、一氧化氮和吸烟在膀胱癌易感性中的相互作用

2025-09-040
OA
Diagnostic Utility of Bronchoalveolar Lavage Flow Cytometric Leukocyte Profiling in Interstitial Lung Disease and Infection

支气管肺泡灌洗液流式细胞术白细胞分型在间质性肺疾病和感染中的诊断效用

2025-04-170
OA
Differential Role of NKG2A/HLA-E Interaction in the Outcomes of Bladder Cancer Patients Treated with M. bovis BCG or Other Therapies
2025-01-100
OAAI
Exploring the Immunoresponse in Bladder Cancer Immunotherapy
CELLS
IF5.2
2024-11-221
OAAI
Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019
2021-04-3030
OA
Immunological Risk Stratification of Bladder Cancer Based on Peripheral Blood Natural Killer Cell Biomarkers

基于外周血自然杀伤细胞生物标志物的膀胱癌免疫危险分层

2021-04-019
PREAI
Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing

KIR抑制配体 (hla-i) 的过表达决定了骨髓瘤的免疫监视依赖于多样化和强大的NK细胞许可

2016-04-0816
OA